Dermacyd PH_DESILSTY_FR (Lactic Acid) - Acceptability - Stay on Frutal

Monocentric Study, Phase III, for Safety Dermatological Evaluation: Acceptability With Gynaecological Follow up - Dermacyd PH_DESILSTY_FR (Lactic Acid).

Status

Completed

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00932945

Enrollment

Registered

2009-07-07

Start date

2009-06-30

Completion date

2009-07-31

Last updated

2010-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hygiene

Brief summary

Primary Objective: To prove the safety of the gynecological formulation in normal conditions of use.

Interventions

DRUGLACTIC ACID(ND)

Treatment duration: 21 consecutive days

Study design

Allocation

NON_RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

PREVENTION

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 65 Years

Healthy volunteers

Yes

Exclusion criteria

* Integral vaginal mucosa in the product analysis region * Use the same category of cosmetics products * Willingness in following the study procedures and to be present in the clinic at the days and scheduled time

Design outcomes

Primary

Measure	Time frame
Evaluation of the absence of irritation and the good acceptability by using one specific scale which describes the intensity of the reaction.	From the treatment start up to the end of the study (treatment period 21 days)

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026